Drug & medication recalls Moderate risk

Taro Pharmaceuticals U.S.A., Inc. recalls Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc.,…

Recall date
September 27, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0298-2020
FDA classification
Class II
Brand / firm
Taro Pharmaceuticals U.S.A., Inc.
Sold / distributed
U.S.A. Nationwide

Why it was recalled

Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Ibuprofen Oral Suspension USP, 100 mg/5 mL, 4 fl. oz., (118 mL), Rx only, Manufactured by: Taro Pharmaceuticals, Inc., Brampton, Ontario, Canada L6T 1C1, Distributed by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1385-8

Get recall alerts

Free email alert whenever Taro Pharmaceuticals U.S.A., Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Taro Pharmaceuticals U.S.A., Inc.